SYSTEMATIC REVIEW article
Front. Public Health
Sec. Digital Public Health
Volume 13 - 2025 | doi: 10.3389/fpubh.2025.1617138
This article is part of the Research TopicAdvancing Healthcare AI: Evaluating Accuracy and Future DirectionsView all 9 articles
Economic, Ethical, and Regulatory Dimensions of Artificial Intelligence in Healthcare: An Integrative Review
Provisionally accepted- 1Almoosa College of Health Sciences, Al Ahsaa, Saudi Arabia
- 2Oslo Metropolitan University, Oslo, Norway
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Artificial Intelligence (AI) is revolutionizing healthcare by improving diagnostic precision, streamlining clinical workflows, and reducing operational costs. Yet, its integration into realworld settings remains fraught with challenges-including economic uncertainty, ethical complexities, fragmented regulatory landscapes, and practical implementation barriers. A growing body of literature highlights that many of AI's purported benefits are derived from idealized models, often failing to reflect the nuances of clinical practice.This integrative review aims to critically evaluate the current evidence on the integration of artificial intelligence into healthcare, with a particular focus on its economic impact, ethical and regulatory challenges, and associated governance and implementation strategies.A comprehensive literature search was conducted across PubMed/MEDLINE, Embase, Web of Science, and the Cochrane Library. Data extraction followed a structured, pre-tested template, and thematic synthesis was employed. Study quality was assessed using an integrated framework combining PRISMA, AMSTAR 2, and the Drummond checklist.Seventeen studies-including systematic reviews, scoping reviews, narrative syntheses, policy analyses, and quantitative case studies-met the inclusion criteria.Three core themes emerged from the analysis. First, while AI interventions-particularly in treatment optimization-are projected to generate significant cost savings and improve operational efficiency, most economic evaluations rely on theoretical models. Many lack transparency regarding key assumptions such as discount rates, sensitivity analyses, and realworld implementation costs, limiting their generalizability. Second, ethical and regulatory concerns persist, with widespread underrepresentation of marginalized populations in training datasets, limited safeguards for patient autonomy, and notable equity disparities across clinical domains. Regulatory frameworks remain fragmented globally, with marked variation in standards for cybersecurity, accountability, and innovation readiness. Third, effective governance and risk management are critical for ensuring safe and sustainable AI integration. Persistent implementation barriers-such as clinician trust deficits, cognitive overload, and data interoperability challenges-underscore the need for robust multidisciplinary collaboration. Maximizing the transformative potential of AI in healthcare will require rigorous economic evaluation, equity-driven design, harmonized global regulation, and inclusive implementation science. The IA²TF Framework provides a foundation for ethically grounded, patient-centered, and financially sustainable AI integration.
Keywords: artificial intelligence, economic evaluation, Ethical Oversight, Regulatory harmonization, Governance frameworks, Risk Management, Clinical implementation, reimbursement models
Received: 29 Apr 2025; Accepted: 19 Aug 2025.
Copyright: © 2025 El Arab, Abdulaziz and Sagbakken. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Mette Sagbakken, Oslo Metropolitan University, Oslo, 0130, Norway
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.